Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Injectable use : Repeated or improper injections can cause localized swelling, redness, and tenderness
Research in PMC shows that NNMT inhibition: Normalizes glucose tolerance Reduces fasting blood glucose levels Increases production of PAHSAs (anti-diabetic lipids) Improves insulin signaling in fat and muscle tissue This makes 5-amino-1MQ particularly interesting for people with prediabetes or metabolic syndrome
Key Regulatory Points as of 2026: Not FDA-approved for any medical indication Cannot legally be sold as a drug, food, or dietary supplement for human consumption Legally sold as a "research chemical," not intended for human use Not a DEA-scheduled substance, so possession is not illegal (unlike anabolic steroids) Many medical clinics offer BPC-157 treatments despite lack of approval The FDA has expressed safety concerns due to the lack of human clinical trial data and the potential for adverse effects from unregulated manufacturing
Bacteriostatic water for injection is defined as a sterile, non-pyrogenic aqueous solution containing 0.9% benzyl alcohol as a preservative per USP 2026 standards
They are not intended for human consumption, veterinary use, or any medical or therapeutic application
Advanced dosing considerations for experienced researchers Once you have mastered the basic calculations, several nuanced factors can further optimize your retatrutide research protocol
.jpg)